MA26816A1 - Derives d'amino-triazolopyridine - Google Patents

Derives d'amino-triazolopyridine

Info

Publication number: MA26816A1
Authority: MA; Morocco
Prior art keywords: amino; triazolopyridine derivatives; triazolopyridine; derivatives
Prior art date: 1999-09-06

Application number

MA26540A

Other languages

English (en)

Inventor

Trottmann Gerda Huber

Roland Jakob-Roetne

Matthias Heinrich Nettekoven

Claus Riemer

Walter Hunkeler

Gavin John Kilpatrick

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-06

Filing date

2002-03-06

Publication date

2004-12-20

2002-03-06 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26816A1 publication Critical patent/MA26816A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Addiction (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

MA26540A 1999-09-06 2002-03-06 Derives d'amino-triazolopyridine MA26816A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99117578		1999-09-06

Publications (1)

Publication Number	Publication Date
MA26816A1 true MA26816A1 (fr)	2004-12-20

Family

ID=8238933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26540A MA26816A1 (fr)	1999-09-06	2002-03-06	Derives d'amino-triazolopyridine

Country Status (22)

Country	Link
US (1)	US6355653B1 (fr)
EP (1)	EP1214322A2 (fr)
JP (1)	JP2003528811A (fr)
KR (1)	KR20020027625A (fr)
CN (1)	CN1379777A (fr)
AR (1)	AR037484A1 (fr)
AU (1)	AU7511000A (fr)
BR (1)	BR0013792A (fr)
CA (1)	CA2383998A1 (fr)
CZ (1)	CZ20021220A3 (fr)
HR (1)	HRP20020172A2 (fr)
HU (1)	HUP0203316A3 (fr)
IL (1)	IL148167A0 (fr)
MA (1)	MA26816A1 (fr)
MX (1)	MXPA02001748A (fr)
NO (1)	NO20021077D0 (fr)
PE (1)	PE20010629A1 (fr)
PL (1)	PL354240A1 (fr)
TR (1)	TR200200579T2 (fr)
WO (1)	WO2001017999A2 (fr)
YU (1)	YU13502A (fr)
ZA (1)	ZA200201055B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6506772B1 (en)	2000-12-15	2003-01-14	Hoffmann-La Roche Inc.	Substituted [1,2,4]triazolo[1,5a]pyridine derivatives with activity as adenosine receptor ligands
US6514989B1 (en) *	2001-07-20	2003-02-04	Hoffmann-La Roche Inc.	Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives
US6693116B2 (en)	2001-10-08	2004-02-17	Hoffmann-La Roche Inc.	Adenosine receptor ligands
KR100614486B1 (ko) *	2001-10-08	2006-08-22	에프. 호프만-라 로슈 아게	8-아미노-[1,2,4]트리아졸로[1,5-ａ]피리딘-6-카복실산아미드
AU2002352933A1 (en)	2001-11-30	2003-06-17	Schering Corporation	[1,2,4]-triazole bicylic adenosine A2a receptor antagonists
HUP0105407A3 (en) *	2001-12-21	2004-04-28	Sanofi Aventis	Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
KR20150080013A (ko)	2002-01-28	2015-07-08	교와 핫꼬 기린 가부시키가이샤	운동성 질환에 걸린 환자의 치료용 조성물
AU2003233127A1 (en) *	2002-06-13	2003-12-31	Pfizer Inc.	Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
US20080033006A1 (en) *	2004-01-26	2008-02-07	Altana Pharma Ag	1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors
ES2327145T3 (es) *	2004-12-21	2009-10-26	Schering Corporation	Anatagonistas del receptor de adenosina a2a de pirazolo(1,5-a)pirimidina sustituidos.
ES2273599B1 (es)	2005-10-14	2008-06-01	Universidad De Barcelona	Compuestos para el tratamiento de la fibrilacion auricular.
US7935715B2 (en) *	2006-07-28	2011-05-03	Boehringer Ingelheim International Gmbh	Compounds which modulate the CB2 receptor
MX2009002888A (es) *	2006-09-25	2009-03-31	Boehringer Ingelheim Int	Compuestos que modulan el receptor cb2.
EP2591675A1 (fr) *	2006-11-27	2013-05-15	H. Lundbeck A/S	Dérivés d'hétéroaryle et d'amide
WO2008065198A1 (fr) *	2006-12-01	2008-06-05	Galapagos N.V.	Composés de triazolopyridine pour le traitement de maladies dégénératives et inflammatoires
WO2008124153A1 (fr) *	2007-04-10	2008-10-16	H. Lundbeck A/S	Analogues d'heteroaryl-amides utilises en tant qu'antagonistes de p2x7
WO2009017954A1 (fr) *	2007-08-01	2009-02-05	Phenomix Corporation	Inhibiteurs de kinase jak2
GB0719803D0 (en)	2007-10-10	2007-11-21	Cancer Rec Tech Ltd	Therapeutic compounds and their use
CA2704684A1 (fr) *	2007-11-07	2009-05-14	Boehringer Ingelheim International Gmbh	Composes modulant le recepteur cb2
JP2011520884A (ja) *	2008-05-13	2011-07-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｂ２受容体を変調するスルホン化合物
BRPI0910021A2 (pt)	2008-06-20	2015-09-01	Genentech Inc	"composto, composição farmacêutica, método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak2 quinas em um paciente, kit para o tratamento de uma doença ou distúrbio responsivo à inibição da jak quinase"
US20100035875A1 (en) *	2008-06-20	2010-02-11	Bing-Yan Zhu	Triazolopyridine jak inhibitor compounds and methods
CA2730037A1 (fr) *	2008-07-10	2010-01-14	Boehringer Ingelheim International Gmbh	Composes sulfones qui modulent le recepteur cb2
TWI453207B (zh) *	2008-09-08	2014-09-21	Signal Pharm Llc	胺基三唑并吡啶，其組合物及使用其之治療方法
PE20110397A1 (es)	2008-09-25	2011-07-01	Boehringer Ingelheim Int	Compuestos que modulan selectivamente el receptor cb2
MY153913A (en) *	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
WO2010141796A2 (fr)	2009-06-05	2010-12-09	Cephalon, Inc.	Préparation et utilisation de dérivés de 1,2,4-triazolo[1,5a]pyridine
US8299103B2 (en) *	2009-06-15	2012-10-30	Boehringer Ingelheim International Gmbh	Compounds which selectively modulate the CB2 receptor
JP5756800B2 (ja)	2009-06-16	2015-07-29	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｂ２受容体を調節するアゼチジン２−カルボキサミド誘導体
US8283465B2 (en) *	2009-07-17	2012-10-09	Japan Tobacco Inc.	Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent
EP2480544A1 (fr) *	2009-09-22	2012-08-01	Boehringer Ingelheim International GmbH	Composés à modulation sélective du récepteur cb2
EP2523936A1 (fr)	2010-01-15	2012-11-21	Boehringer Ingelheim International GmbH	Composés qui modulent le récepteur cb2
US8329735B2 (en)	2010-03-05	2012-12-11	Boehringer Ingelheim International Gmbh	Tetrazole compounds which selectively modulate the CB2 receptor
WO2012012307A1 (fr)	2010-07-22	2012-01-26	Boehringer Ingelheim International Gmbh	Composés sulfonylés qui modulent le récepteur cb2
WO2013041472A1 (fr) *	2011-09-19	2013-03-28	F. Hoffmann-La Roche Ag	Composés triazolopyridines en tant qu'inhibiteurs de pde10a
EP2757883B1 (fr) *	2011-09-22	2021-01-13	Merck Sharp & Dohme Corp.	Composés triazolopyridyle à utiliser en tant qu'inhibiteurs de l'aldostérone synthase
EP2757882B1 (fr)	2011-09-22	2020-11-04	Merck Sharp & Dohme Corp.	Composés imidazopyridyliques utilisables en tant qu'inhibiteurs de l'aldostérone synthase
EP2803668A1 (fr)	2013-05-17	2014-11-19	Boehringer Ingelheim International Gmbh	Nouveau (cyano-dimethyl-methyl)-isoxazoles et - [1,3,4] thiadiazoles
BR112018068681A2 (pt)	2016-03-16	2019-01-15	Bayer Cropscience Ag	derivados de n-(cianobenzil)-6-(ciclopropil-carbonilamino)-4-(fenil)-piridina-2-carboxamida e compostos relacionados como pesticidas e agentes de proteção de plantas
CN106543175B (zh) *	2016-10-28	2018-06-01	上海大学	三芳基[1,2,4]三氮唑[1,5-a]吡啶衍生物及其制备方法
RU2764655C2 (ru) *	2017-03-16	2022-01-19	Цзянсу Хэнжуй Медицин Ко., Лтд.	ПРОИЗВОДНОЕ ГЕТЕРОАРИЛ[4,3-с]ПИРИМИДИН-5-АМИНА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКИЕ ПРИМЕНЕНИЯ
MX2020008949A (es)	2018-02-27	2021-01-08	Incyte Corp	Imidazopirimidinas y triazolopirimidinas como inhibidores de a2a / a2b.
JP7391046B2 (ja)	2018-05-18	2023-12-04	インサイト・コーポレイション	Ａ２ａ／ａ２ｂ阻害剤としての縮合ピリミジン誘導体
IL279829B2 (en)	2018-07-05	2025-05-01	Incyte Holdings Corp	Fused pyrazine derivatives as A2A/A2B inhibitors
JP7399589B2 (ja) *	2018-09-12	2023-12-18	日本化薬株式会社	有害生物防除剤
SG11202106582YA (en)	2018-12-20	2021-07-29	Incyte Corp	Imidazopyridazine and imidazopyridine compounds as inhibitors of activin receptor-like kinase-2
TWI829857B (zh)	2019-01-29	2024-01-21	美商英塞特公司	作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
CN115867553A (zh) *	2021-01-09	2023-03-28	巴格沃克斯研究有限公司	作为腺苷2A受体和腺苷2B受体拮抗剂的二氨基吡唑[1,5-a]并嘧啶-6-腈化合物
CN116082335A (zh) *	2023-01-16	2023-05-09	上海凌凯医药科技有限公司	一种二芳基醚化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9226735D0 (en)	1992-12-22	1993-02-17	Ici Plc	Azole derivatives
WO1999043678A1 (fr)	1998-02-24	1999-09-02	Kyowa Hakko Kogyo Co., Ltd.	Medicaments et prophylaxie contre la maladie de parkinson

2000
- 2000-08-24 US US09/645,127 patent/US6355653B1/en not_active Expired - Fee Related
- 2000-08-28 IL IL14816700A patent/IL148167A0/xx unknown
- 2000-08-28 PL PL00354240A patent/PL354240A1/xx not_active Application Discontinuation
- 2000-08-28 JP JP2001522222A patent/JP2003528811A/ja active Pending
- 2000-08-28 CN CN00812501A patent/CN1379777A/zh active Pending
- 2000-08-28 TR TR2002/00579T patent/TR200200579T2/xx unknown
- 2000-08-28 WO PCT/EP2000/008372 patent/WO2001017999A2/fr not_active Ceased
- 2000-08-28 HU HU0203316A patent/HUP0203316A3/hu unknown
- 2000-08-28 MX MXPA02001748A patent/MXPA02001748A/es unknown
- 2000-08-28 KR KR1020027002990A patent/KR20020027625A/ko not_active Ceased
- 2000-08-28 AU AU75110/00A patent/AU7511000A/en not_active Abandoned
- 2000-08-28 CZ CZ20021220A patent/CZ20021220A3/cs unknown
- 2000-08-28 HR HR20020172A patent/HRP20020172A2/hr not_active Application Discontinuation
- 2000-08-28 CA CA002383998A patent/CA2383998A1/fr not_active Abandoned
- 2000-08-28 BR BR0013792-8A patent/BR0013792A/pt not_active IP Right Cessation
- 2000-08-28 EP EP00964043A patent/EP1214322A2/fr not_active Withdrawn
- 2000-08-28 YU YU13502A patent/YU13502A/sh unknown
- 2000-09-04 AR ARP000104612A patent/AR037484A1/es not_active Application Discontinuation
- 2000-09-04 PE PE2000000903A patent/PE20010629A1/es not_active Application Discontinuation
2002
- 2002-02-06 ZA ZA200201055A patent/ZA200201055B/xx unknown
- 2002-03-05 NO NO20021077A patent/NO20021077D0/no not_active Application Discontinuation
- 2002-03-06 MA MA26540A patent/MA26816A1/fr unknown

Also Published As

Publication number	Publication date
HUP0203316A3 (en)	2004-07-28
CN1379777A (zh)	2002-11-13
PL354240A1 (en)	2003-12-29
IL148167A0 (en)	2002-09-12
WO2001017999A3 (fr)	2001-12-06
NO20021077L (no)	2002-03-05
ZA200201055B (en)	2003-07-30
BR0013792A (pt)	2002-05-14
CZ20021220A3 (cs)	2002-10-16
HUP0203316A2 (hu)	2003-01-28
HRP20020172A2 (en)	2003-10-31
TR200200579T2 (tr)	2002-12-23
NO20021077D0 (no)	2002-03-05
YU13502A (sh)	2004-11-25
EP1214322A2 (fr)	2002-06-19
MXPA02001748A (es)	2002-08-06
KR20020027625A (ko)	2002-04-13
AU7511000A (en)	2001-04-10
CA2383998A1 (fr)	2001-03-15
PE20010629A1 (es)	2001-05-30
JP2003528811A (ja)	2003-09-30
US6355653B1 (en)	2002-03-12
WO2001017999A2 (fr)	2001-03-15
AR037484A1 (es)	2004-11-17

Publication	Publication Date	Title
MA26816A1 (fr)	2004-12-20	Derives d'amino-triazolopyridine
MA26831A1 (fr)	2004-12-20	Derives de benzodiazepine."
IS2116B (is)	2006-06-15	4-fenyl-pyridin afleiður
DE60009747D1 (de)	2004-05-13	Admantan-derivate
DE50010060D1 (de)	2005-05-19	Thiazolylamid-derivate
IS6128A (is)	2001-10-26	13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da)	2004-12-20	5-phenyl-pyrimidinderivater
NO20021803D0 (no)	2002-04-17	Isoksazolkarboksamid-derivater
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
DK1154988T3 (da)	2004-11-22	Mevinolinderivater
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
DK1218340T3 (da)	2004-03-29	4-hydroxybiphenylhydrazid-derivater
DK1187815T3 (da)	2006-06-19	4-phenyl-pyrimidinderivater
ATE293592T1 (de)	2005-05-15	Resorcinderivate
TR200002831A3 (tr)	2001-04-20	Kinolin-4-Il türevleri I
DK1189886T3 (da)	2006-05-15	Ethansulfonyl-piperidinderivater
MA27240A1 (fr)	2005-03-01	Derives d'imidazoquinoleine
NO20022867D0 (no)	2002-06-14	Syklopentenon-derivater
NO20020212D0 (no)	2002-01-15	3-amino-2-benzyl-1-fenyl-propanderivater
PT1060183E (pt)	2003-08-29	Derivados de 5'-desoxicitidina
DE60001736D1 (de)	2003-04-24	1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate
EP1192168A4 (fr)	2003-04-16	Galectine 11
ATE243218T1 (de)	2003-07-15	2''-deoxyhygromycinderivate
DE59909774D1 (de)	2004-07-22	1-cycloalkylpyrazolyl-benzoyl-derivate
MA26481A1 (fr)	2004-12-20	Derives d'arylsecocholadiene